Pioneering neuroendocrinologist's century of discovery launches major scientific tribute series

Opening article in landmark Festschrift series honors Dr. Seymour Reichlin's 100 years of groundbreaking brain-hormone research

2024-11-05

(Press-News.org) Tucson, Arizona, 5 November 2024 – Brain Medicine has launched an ambitious Festschrift series with the first of more than ten planned articles celebrating Dr. Seymour Reichlin's centennial year and his transformative impact on neuroendocrinology. The opening editorial, chronicling his revolutionary insights into brain-hormone interactions, inaugurates what promises to be one of the most comprehensive tributes in the field's history.

“One could be both a physician caring for patients and a scientific investigator,” reflects Dr. Reichlin, whose work spanning nearly 80 years has fundamentally reshaped our understanding of how the brain and hormones interact. Still actively contributing to scientific discourse at 100 years old, his early experiences as a psychiatric orderly during World War II sparked a lifelong quest to understand the biological mechanisms of stress and emotional states.

“Dr. Reichlin's influence extends far beyond his scientific achievements,” notes Dr. Ronald Lechan, lead author of the inaugural editorial. “His ability to excite fellows about research, coupled with his innovative thinking and clear vision of important questions to pursue, has shaped generations of leading endocrinologists.”

The forthcoming series will explore multiple facets of Dr. Reichlin's contributions, including:

• Pioneering work on hypothalamic control of pituitary function

• Development of the first radioimmunoassay for several crucial hormones

• Groundbreaking discoveries in psychoneuroimmunology

• Early recognition of fat tissue as an endocrine organ

• Identification of the first somatostatinoma

Currently, Dr. Reichlin is writing two books: one examining the neuroendocrinology of Alzheimer's disease, and another exploring the neurobiological basis of ecstatic mysticism. These newest endeavors raise intriguing questions that subsequent articles in the series may address: How might understanding the neuroendocrine basis of mystical experiences provide new insights into stress adaptation? What can Dr. Reichlin's early observations about fat as an endocrine organ teach us about modern obesity challenges?

“The upcoming articles in this series will demonstrate how Dr. Reichlin's foundational work continues to influence cutting-edge research across multiple fields," adds Dr. Lechan. "Each contribution will explore different aspects of his legacy while highlighting new directions for future investigation.”

Drs. Lechan and Toni's Guest Editorial marks the beginning of a landmark Festschrift series in Brain Medicine honoring Dr. Seymour Reichlin and his contributions to neuroendocrinology. The series is edited By Alan Harris, George Chrousos, and Julio Licinio. Additional papers in this series will be published throughout 2024-2025, featuring perspectives from leading researchers worldwide. Each contribution will present either original research, personal reflections, or a combination of both, offering readers a comprehensive view of Dr. Reichlin's seminal work within the broader landscape of neuroendocrinology. By weaving together scientific advances with personal insights, this Festschrift creates a rich narrative that both educates and engages, serving as a valuable resource for anyone interested in neuroendocrinology, as well as colleagues, students, and friends of Dr. Reichlin while illuminating universal themes in scientific discovery. For additional information about this Festschrift series, please contact support@genomicpress.com.

The full Guest Editorial, titled “An overview of the life and career of Seymour Reichlin, MD, PhD” is available on 5 November 2024 in Brain Medicine, providing detailed insights into Dr. Reichlin’s extraordinary life and career. The Guest Editorial is freely available online at https://url.genomicpress.com/2wyvzmjm.

About Brain Medicine: Brain Medicine (ISSN: 2997-2639) is a peer-reviewed journal published by Genomic Press, New York. Brain Medicine is a new home for the cross-disciplinary pathway from innovation in fundamental neuroscience to translational initiatives in brain medicine. The journal’s scope includes the underlying science, causes, outcomes, treatments, and societal impact of brain disorders, across all clinical disciplines and their interface.

END

[Attachments] See images for this press release:

Pioneering neuroendocrinologist's century of discovery launches major scientific tribute series 2

ELSE PRESS RELEASES FROM THIS DATE:

Gendered bilingualism in post-colonial Korea

2024-11-05

In the 1960s, Japanese books became immensely popular in South Korea. Interestingly, Korean newspapers often wrote about this trend as if mainly women were interested in learning Japanese. Osaka Metropolitan University Associate Professor Jinsuk Yang examined South Korean newspaper articles and other historical documents from the 1960s and 1970s to understand why Japanese language learning was often described as something women did, even though men were also learning Japanese. Additionally, Professor Yang studied how women’s ability to speak Japanese affected ...

Structural safety monitoring of buildings with color variations

2024-11-05

As buildings age, the demand for effective monitoring of their structural integrity has grown significantly. A breakthrough in nano-optical sensor technology now enables precise, real-time measurement of structural deformation and stability. This innovation promises to reshape the field of structural diagnostics, offering a cost-effective, time-efficient solution that reduces the need for specialized expertise traditionally required in this area. Led by Dr. Jae Sung Yoon, Principal Researcher at the Nano-lithography & Manufacturing Research Center within the Nano-convergence ...

Bio-based fibers could pose greater threat to the environment than conventional plastics

2024-11-05

Bio-based materials may pose a greater health risk to some of the planet’s most important species than the conventional plastics they are designed to replace, a new study has shown. Such materials are increasingly being advocated as environmentally friendly alternatives to plastics, and used in textiles and products including clothing, wet wipes and period products. However, microfibres of the materials are emitted into the environment through the laundry cycle, the application of sewage sludge as fertilisers, or the simple wear and tear of textile products. Despite increasing quantities of bio-based products being produced and sold all over the world, there has been ...

Bacteria breakthrough could accelerate mosquito control schemes

2024-11-05

Mosquito larvae grow faster if they’re exposed to particular bacteria, according to a new study that could help global health programmes. Aedes aegypti mosquitoes spread illnesses including dengue, yellow fever and Zika. Anti-disease programmes breed and release non-biting male mosquitoes that are either sterile or prevent transmission of diseases. These mass release programmes can be substantially more effective than the widespread spraying of insecticides, as these insects have developed resistance to many commonly employed chemicals. The new study, by ...

Argonne to help drive AI revolution in astronomy with new institute led by Northwestern University

2024-11-04

The U.S. National Science Foundation and Simons Foundation have selected a group of institutions, including Argonne, to receive funding to establish an AI and astronomy institute called the NSF-Simons AI Institute for the Sky (SkAI). Part of a groundbreaking effort to harness artificial intelligence (AI) to unlock the mysteries of the cosmos, the U.S. Department of Energy’s (DOE) Argonne National Laboratory is a key collaborator in the newly launched NSF-Simons AI Institute ...

Medicaid funding for addiction treatment hasn’t curbed overdose deaths

2024-11-04

For generations, the federal government has largely refrained from paying for mental health and substance use treatment in large residential facilities. That changed in 2015 when, in response to increasing overdose deaths nationwide from illicit drugs, the federal government allowed states to waive a longstanding prohibition against using federal Medicaid funding for services in so-called institutions of mental diseases. In turn, states were required to improve their addiction care with an emphasis on increasing treatment with medications. Yet a new study by researchers at Oregon Health & Science University finds no overall ...

UVA co-leads $2.9 million NIH investigation into where systems may fail people with disabilities

2024-11-04

A University of Virginia School of Engineering and Applied Science researcher is partnering on a historic and foundational National Institutes of Health study to help the nation discuss, and better address, the concept of structural ableism and where it may result in healthcare disparities. Rupa Valdez, a professor of systems and information engineering who also holds an appointment as a professor of public health sciences in the UVA School of Medicine, is co-leading the five-year, $2.9 million investigation — the first of its kind. Currently, the field relies on non-standardized ...

With the help of AI, UC Berkeley researchers confirm Hollywood is getting more diverse

2024-11-04

With recent box office hits like Black Panther: Wakanda Forever, The Little Mermaid and Everything Everywhere All at Once, the average viewer might assume that the casts of Hollywood films are more diverse now than they were 10 or 20 years ago. But verifying these perceptions can be tricky. Even before the #OscarsSoWhite social media campaign in 2015 brought much-needed attention to the lack of diversity in Academy-nominated films, film scholars had begun documenting the lack of representation of women and actors of color in Hollywood. Doing so requires that they watch ...

Weight loss interventions associated with improvements in several symptoms of PCOS

2024-11-04

Embargoed for release until 5:00 p.m. ET on Monday 4 November 2024 @Annalsofim         Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.         ----------------------------         1. ...

Federal government may be overpaying for veterans’ health care in Medicare Advantage plans

2024-11-04

Key points: Approximately one in five of the veterans enrolled in a high-veteran Medicare Advantage (MA) plan did not incur any Medicare services paid by MA within a given year and instead received their health care through the Department of Veterans Affairs (VA). In 2020, the Centers for Medicare and Medicaid Services (CMS) paid more $1 billion to MA plans for enrolling VA-enrollees who did not utilize Medicare services, with nearly 20% of that funding directed disproportionately to high-veteran MA plans. The ...